NK/T Cell Lymphoma — Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
Citation(s)
A Pilot Study of Nivolumab in Combination With GDP (Gemcitabine, Dexamethasone, Cisplatin)/ L-asparaginase in Patients With Advanced Stage or Relapsed/ Refractory Natural-killer/ T-cell Lymphoma